Impact of Periprocedural Myocardial Infarction on In-Hospital and 2-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

Background:
There are few studies comparing the long-term clinical outcomes of patients (pts) with peri-procedural myocardial infarction (P-MI) with those without P-MI following percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) in real world clinical practice. Methods: A total of 1119 pts underwent PCI with DESs between 2004 and 2010 were enrolled (control group, nϭ1006 pts and P-MI group, nϭ113 pts). P-MI was defined as major CK-MB elevation (Ն3X the upper limit of normal [ULN]) after PCI. Results: There were no significant differences between the two groups except P-MI group was more elderly, had more female, longer procedure time, higher number of target vessel and stents. At 6 month routine follow-up angiography, there was no significant difference in mean diameter stenosis %, incidence of binary restenosis and late loss between the two groups. Among the major in-hospital outcomes, cardiac death was higher in P-MI group. At 2-year (follow-up, 89.1%), and the cumulative incidence of total death, cardiac death and total major adverse cardiac events (MACEs) were higher in P-MI group, where as repeat PCI including target lesion revascularization (TLR) and target vessel revascularization (TVR). However, when in-hospital mortality was excluded, the major clinical outcomes were not different between the two groups up to 2 years (table) . Conclusions: P-MI was mainly associated with in-hospital cardiac death following PCI with DES in real world clinical practice. However, P-MI doesn't seem to be an independent predictor for adverse clinical outcomes for long-term period.
TCT-627
Does direct DES stenting reduces restenosis; a randomized comparison of direct stent implantation to stenting with predilation or provisional stenting in elective PCI patients Background: Previous studies were performed to investigate whether a strategy of direct stent implantation without pre-dilatation is associated with a reduced incidence of restenosis, compared to conventional stenting with pre-dilatation. However, none of these studies were performed in the drug-eluting stent era. Therefore the STRESSED (direct Stenting To Reduce REStenosis in Stent Era with Drug elution) study was designed and carried out. Methods: A total of 600 patients with stable or unstable angina pectoris or a recent (Ͻ30 days) myocardial infarction were randomized to direct stenting, stenting after predilatation or a provisional stenting strategy. Primary endpoint was the mean minimal lumen diameter (MLD) at 9 months follow-up angiography. Secondary endpoints were the clinical procedural success defined as angiographic success without major adverse cardiac events (MACE) at 9 months and two years follow-up. Conclusions: Direct drug-eluting stenting did not reduce restenosis, when compared tot conventional DES stenting. Provisional stenting was associated with a higher rate of restenosis, however, no differences was observed in the rate of MACE during 9-month follow-up, The 2 year clinical follow-up will be presented at the conference.
P O S T E R S Results:
TCT-628
Drug-eluting stent implantation for the treatment of bare-metal or drugeluting stent restenosis Background: In the drug-eluting-stent (DSE) era, the rate of in-stent restenosis (ISR) was substantially decreased. Previous randomized trials have suggested that DES implantation may be efficacious to decrease incidence of repeated ISR. The purpose of this study was to assess the efficacy of DES implantation for the treatment of ISR after bare-metal stent (BMS) or DES implantation. Methods: A total of 120 consecutive patients who developed ISR was included in this study. Angiographical follow-up was performed in 78 of 120 patients (BMS 67, DES 53). We compared the angiographical restenosis rate between the patients who underwent percutaneous coronary intervention (PCI) using DES (DES group) and the patients who underwent PCI using balloon angioplasty (balloon group). Results: Overall rate of re-ISR was significantly lower in DES group than in balloon group (16% vs, 39%, pϽ0.05). In the subset of patients with BMS restenosis (nϭ41), rate of re-ISR between DES group and POBA group (17% vs, 24%, pϭNS). On the other hand, ISR patients after DES implantation (nϭ37) showed significantly lower rate of re-ISR in DES group than that in POBA group (17% vs, 53%, pϽ0.05). Conclusions: The efficacy of DES implantation for the treatment of ISR might be affected by the index stent types. 
TCT-629
Real-World Comparison of Clinical Outcomes of Patients who Received New Generation Platinum Chromium Everolimus-Eluting Stent Versus Cobalt Chromium Everolimus-Eluting Stent
Conclusions:
This new generation BMS with very thin struts and passive coating shows excellent results through all subgroups, also confirmed in low MACE rates for AMI, elderly, small vessels and diabetic subjects. Utility of such modern BMS platforms are still very relevant in the era of DES.
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